DP Medical to launch Chitogel™ in Ireland at IOS 2024

The team from DP Medical will be officially launching Chitogel™ in Ireland this month, at the Irish Otorhinolaryngology / Head and Neck Surgery Society Conference in Belfast.

Taking place on Friday 11th and Saturday 12th October, DP Medical is sponsoring the two-day event, which features an in-depth programme of panel discussions, keynote addresses and seminars with some of the world’s leading professionals in the field of ENT and head and neck surgery.

The event marks the official launch of Chitogel™ in Ireland and follows the announcement of DP Medical as the exclusive UK and Ireland supplier of Chitogel™ earlier this year, bringing the Chitogel Endoscopic Sinus Surgery Kit to the UK and Ireland for the first time.

The product is a clinically proven hydrogel which supports rapid and complete wound healing, minimising adhesions, preserving structural integrity and addressing patient comfort.

Alongside Chitogel™ at DP Medical’s stand will be cutting-edge ENT equipment from XION Medical, as well as the Trachealator non-occulsive airway ballon from Disa Medinotec, and APrevent’s VOIS Implant.

Thomas Cryan, sales director at DP Medical, said: “We’re excited to be heading to this year’s IOS Conference – a key event in Ireland’s ENT calendar – to launch Chitogel™ to the Irish market at an event which brings together leaders from across the sector to discuss the latest advancements in treatment and technology.

“Alongside this exciting new addition to our product line, we’ll also have our range of innovative ENT devices on show and available for demonstration, giving attendees the chance to see the range we offer exclusively to the UK and Ireland in person, exploring each product’s capabilities with our team on hand to answer any questions.”

Commenting on the launch of Chitogel™ earlier this year, Edward Lamb, CEO of Chitogel, said: “We are extremely excited to partner with DP Medical as we continue our global growth plans, which include Europe and Asia over the coming 12 months. Chitogel has demonstrated a 70 percent reduction in revision surgery, giving a positive health economic outcome as well”.

For the full IOS 2024 programme, visit: https://iosconference.org/IOS%20Conference%20Belfast%20Program.pdf